BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 10073400)

  • 41. Localization of a novel t(1;7) translocation associated with Wilms' tumor predisposition and skeletal abnormalities.
    Reynolds PA; Powlesland RM; Keen TJ; Inglehearn CF; Cunningham AF; Green ED; Brown KW
    Genes Chromosomes Cancer; 1996 Nov; 17(3):151-5. PubMed ID: 8946193
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chromosome analysis of 31 Wilms' tumors.
    Sheng WW; Soukup S; Bove K; Gotwals B; Lampkin B
    Cancer Res; 1990 May; 50(9):2786-93. PubMed ID: 2158398
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of novel regions of deletion in familial Wilms' tumor by comparative genomic hybridization.
    Altura RA; Valentine M; Li H; Boyett JM; Shearer P; Grundy P; Shapiro DN; Look AT
    Cancer Res; 1996 Aug; 56(16):3837-41. PubMed ID: 8706032
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Loss of heterozygosity for chromosomes 16q and 1p in Wilms' tumors predicts an adverse outcome.
    Grundy PE; Telzerow PE; Breslow N; Moksness J; Huff V; Paterson MC
    Cancer Res; 1994 May; 54(9):2331-3. PubMed ID: 8162576
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetics of embryonal tumours of childhood: retinoblastoma, Wilms' tumour and neuroblastoma.
    Brodeur GM
    Cancer Surv; 1995; 25():67-99. PubMed ID: 8718513
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Wilms tumor and the WT1 gene.
    Lee SB; Haber DA
    Exp Cell Res; 2001 Mar; 264(1):74-99. PubMed ID: 11237525
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Wilms' tumour: connecting tumorigenesis and organ development in the kidney.
    Rivera MN; Haber DA
    Nat Rev Cancer; 2005 Sep; 5(9):699-712. PubMed ID: 16110318
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Upregulation of c-MYC in WT1-mutant tumors: assessment of WT1 putative transcriptional targets using cDNA microarray expression profiling of genetically defined Wilms' tumors.
    Udtha M; Lee SJ; Alam R; Coombes K; Huff V
    Oncogene; 2003 Jun; 22(24):3821-6. PubMed ID: 12802290
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Linkage of familial Wilms' tumor predisposition to chromosome 19 and a two-locus model for the etiology of familial tumors.
    McDonald JM; Douglass EC; Fisher R; Geiser CF; Krill CE; Strong LC; Virshup D; Huff V
    Cancer Res; 1998 Apr; 58(7):1387-90. PubMed ID: 9537236
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An overview of the clinical and molecular genetics of Wilms' tumor.
    Grundy P; Coppes M
    Med Pediatr Oncol; 1996 Nov; 27(5):394-7. PubMed ID: 8827064
    [No Abstract]   [Full Text] [Related]  

  • 51. A developmental context for multiple genetic alterations in Wilms' tumor.
    Feinberg AP
    J Cell Sci Suppl; 1994; 18():7-12. PubMed ID: 7883796
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Genetics of renal tumors].
    Oláh E; Jakab Z; Balogh E
    Orv Hetil; 2001 Jul; 142(26):1367-73. PubMed ID: 11478032
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The same mutation affecting the splicing of WT1 gene is present on Frasier syndrome patients with or without Wilms' tumor.
    Barbosa AS; Hadjiathanasiou CG; Theodoridis C; Papathanasiou A; Tar A; Merksz M; Györvári B; Sultan C; Dumas R; Jaubert F; Niaudet P; Moreira-Filho CA; Cotinot C; Fellous M
    Hum Mutat; 1999; 13(2):146-53. PubMed ID: 10094551
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transcriptional regulation by the Wilms' tumour suppressor protein WT1.
    Wagner KJ; Roberts SG
    Biochem Soc Trans; 2004 Dec; 32(Pt 6):932-5. PubMed ID: 15506928
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The familial Wilms' tumour susceptibility gene, FWT1, may not be a tumour suppressor gene.
    Rahman N; Arbour L; Tonin P; Baruchel S; Pritchard-Jones K; Narod SA; Stratton MR
    Oncogene; 1997 Jun; 14(25):3099-102. PubMed ID: 9223674
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 16q heterozygosity loss in Wilms' tumour in children and its clinical importance.
    Skotnicka-Klonowicz G; Rieske P; Bartkowiak J; Szymik-Kantorowicz S; Daszkiewicz P; Debiec-Rychter M
    Eur J Surg Oncol; 2000 Feb; 26(1):61-6. PubMed ID: 10718182
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Imbalanced expression of functionally different WT1 isoforms may contribute to sporadic unilateral Wilms' tumor.
    Liu JJ; Wang ZY; Deuel TF; Xu YH
    Biochem Biophys Res Commun; 1999 Jan; 254(1):197-9. PubMed ID: 9920757
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Constitutional and somatic mutations in the WT1 gene in Wilms' tumor patients.
    Nordenskjöld A; Friedman E; Sandstedt B; Söderhäll S; Anvret M
    Int J Cancer; 1995 Nov; 63(4):516-22. PubMed ID: 7591260
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular genetics of Wilms tumor.
    Grundy P; Coppes MJ; Haber D
    Hematol Oncol Clin North Am; 1995 Dec; 9(6):1201-15. PubMed ID: 8591961
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Loss of heterozygosity at chromosome 11p15 in Wilms tumors: identification of two independent regions.
    Karnik P; Chen P; Paris M; Yeger H; Williams BR
    Oncogene; 1998 Jul; 17(2):237-40. PubMed ID: 9674708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.